Nektar Therapeutics Statistics
Total Valuation
NKTR has a market cap or net worth of $133.03 million. The enterprise value is $99.03 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NKTR has 186.10 million shares outstanding. The number of shares has increased by 9.53% in one year.
| Current Share Class | 186.10M |
| Shares Outstanding | 186.10M |
| Shares Change (YoY) | +9.53% |
| Shares Change (QoQ) | -1.25% |
| Owned by Insiders (%) | 1.31% |
| Owned by Institutions (%) | 65.32% |
| Float | 173.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.72 |
| Forward PS | 1.65 |
| PB Ratio | 9.68 |
| P/TBV Ratio | 9.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.24, with a Debt / Equity ratio of 13.59.
| Current Ratio | 3.24 |
| Quick Ratio | 3.11 |
| Debt / Equity | 13.59 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.07 |
Financial Efficiency
Return on equity (ROE) is -189.46% and return on invested capital (ROIC) is -31.27%.
| Return on Equity (ROE) | -189.46% |
| Return on Assets (ROA) | -26.80% |
| Return on Invested Capital (ROIC) | -31.27% |
| Return on Capital Employed (ROCE) | -75.46% |
| Revenue Per Employee | $1.43M |
| Profits Per Employee | -$2.18M |
| Employee Count | 61 |
| Asset Turnover | 0.27 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -152,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.39% in the last 52 weeks. The beta is 0.63, so NKTR's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | -59.39% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 1.02 |
| Relative Strength Index (RSI) | 52.75 |
| Average Volume (20 Days) | 2,079,957 |
Short Selling Information
The latest short interest is 8.93 million, so 4.80% of the outstanding shares have been sold short.
| Short Interest | 8.93M |
| Short Previous Month | 8.14M |
| Short % of Shares Out | 4.80% |
| Short % of Float | 5.13% |
| Short Ratio (days to cover) | 3.15 |
Income Statement
In the last 12 months, NKTR had revenue of $87.25 million and -$133.04 million in losses. Loss per share was -$0.63.
| Revenue | 87.25M |
| Gross Profit | 65.10M |
| Operating Income | -139.83M |
| Pretax Income | -177.16M |
| Net Income | -133.04M |
| EBITDA | -136.62M |
| EBIT | -139.83M |
| Loss Per Share | -$0.63 |
Full Income StatementBalance Sheet
The company has $218.63 million in cash and $186.66 million in debt, giving a net cash position of $33.99 million or $0.18 per share.
| Cash & Cash Equivalents | 218.63M |
| Total Debt | 186.66M |
| Net Cash | 33.99M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | 13.74M |
| Book Value Per Share | 0.07 |
| Working Capital | 158.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$176.87 million and capital expenditures -$1.31 million, giving a free cash flow of -$178.19 million.
| Operating Cash Flow | -176.87M |
| Capital Expenditures | -1.31M |
| Free Cash Flow | -178.19M |
| FCF Per Share | -$0.96 |
Full Cash Flow StatementMargins
Gross margin is 74.61%, with operating and profit margins of -160.27% and -152.49%.
| Gross Margin | 74.61% |
| Operating Margin | -160.27% |
| Pretax Margin | -152.66% |
| Profit Margin | -152.49% |
| EBITDA Margin | -156.59% |
| EBIT Margin | -160.27% |
| FCF Margin | n/a |
Dividends & Yields
NKTR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.53% |
| Shareholder Yield | -9.53% |
| Earnings Yield | -100.01% |
| FCF Yield | -133.95% |
Analyst Forecast
The average price target for NKTR is $4.92, which is 588.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.92 |
| Price Target Difference | 588.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 9.95% |
| EPS Growth Forecast (5Y) | 1.47% |
Stock ForecastsStock Splits
The last stock split was on August 23, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 23, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
NKTR has an Altman Z-Score of -20.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -20.1 |
| Piotroski F-Score | 3 |